Inactivated SARS-CoV-2 vaccine (Vero cell) (Wuhan Institute Of Biological Products)

新型冠状病毒肺炎灭活疫苗（Vero细胞）（武汉生物制品研究所）

Report date: 2023/11/01 10:57:51

Base Information

Drug NameInactivated SARS-CoV-2 vaccine (Vero cell) (Wuhan Institute Of Biological Products)
Drug Alias Name众康可维COVILO
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaCoronavirus Disease 2019 (COVID-19)
Original Approved Country/TerritoryMainland China
Original Approved Date2021/02/25
Country/TerritoryBahrainUnited Arab EmiratesEgypt +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversidad Peruana Cayetano Heredia, Lima, PeruCayetano Heredia UniversityWuhan Institute Of Biological Products Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeJ07B
Related LinksN/A